BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Nonalcoholic fatty liver disease
1
Loop ileostomy-induced reversible nonalcoholic fatty liver disease in a rectal cancer patient: A case report and review of literature
4/24/2026 10:11:12 AM | Browse: 68 | Download: 222
2
Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease
1/27/2026 10:12:30 AM | Browse: 225 | Download: 320
3
Phase III, multicenter, randomized, double-blind, placebo-controlled study of norursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease patients
12/26/2025 10:27:34 AM | Browse: 365 | Download: 707
4
Clinical and biological significance of the relationship between gut microbiota and liver disease
12/26/2025 10:27:30 AM | Browse: 221 | Download: 483
5
Quick glance at 'metabolic dysfunction associated steatotic liver disease' therapeutics: Targets, trials, and trends
12/5/2025 11:28:02 AM | Browse: 177 | Download: 429
6
Essential phospholipids and enzyme-based staging in nonalcoholic fatty liver disease: A call to action
11/27/2025 7:53:52 AM | Browse: 128 | Download: 409
7
Link between type 2 diabetes mellitus and hepatocellular carcinoma
7/25/2025 12:09:46 PM | Browse: 310 | Download: 470
8
Construction of a community-based primary screening and hospital-based confirmatory screening pathway in pediatric nonalcoholic fatty liver disease
7/24/2025 7:47:20 AM | Browse: 163 | Download: 702
9
Risk of hepatocellular carcinoma according to body mass index and waist circumference in nonalcoholic fatty liver disease
6/13/2025 1:39:34 PM | Browse: 334 | Download: 1014
10
Diagnostic accuracy of noninvasive steatosis biomarkers with magnetic resonance imaging proton density fat fraction as gold standard
5/26/2025 7:26:12 AM | Browse: 280 | Download: 1031
11
Role of autoimmune phenomena in nonalcoholic fatty liver disease: Insights and limitations
3/26/2025 4:06:58 AM | Browse: 199 | Download: 565
12
Non-alcoholic fatty liver disease and drug induced liver injury: A metabolic storm waiting to happen
3/26/2025 4:06:56 AM | Browse: 319 | Download: 715
13
Research hotspots and trends in gut microbiota and nonalcoholic fatty liver disease: A bibliometric study
1/6/2025 8:47:56 AM | Browse: 345 | Download: 859
14
What is the role of nonalcoholic fatty liver disease in pulmonary carcinoma development?
12/30/2024 9:49:59 AM | Browse: 347 | Download: 846
15
Revolutionizing the understanding of liver disease: Metabolism, function and future
11/29/2024 2:50:19 PM | Browse: 362 | Download: 1049
16
Evaluation of autoimmune phenomena in patients with nonalcoholic fatty liver disease on the basis of liver pathology
11/29/2024 2:50:19 PM | Browse: 358 | Download: 1318
17
Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus
11/29/2024 2:50:18 PM | Browse: 357 | Download: 1277
18
Effect of Dendrobium nobile powder combined with conventional therapy on mild to moderate fatty liver
11/13/2024 10:10:51 AM | Browse: 120 | Download: 625
19
Potential of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease: A promising future
10/31/2024 10:42:49 AM | Browse: 369 | Download: 922
20
Cardiovascular and Nonalcoholic Fatty Liver Disease: Sharing Common Ground through SIRT1 Pathways
10/31/2024 8:01:10 AM | Browse: 294 | Download: 796
21
Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis
10/25/2024 3:02:15 AM | Browse: 364 | Download: 895
22
Role of cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes pathway in diabetes and its complications
9/26/2024 8:51:02 AM | Browse: 245 | Download: 819
23
Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis
8/21/2024 11:22:32 PM | Browse: 282 | Download: 838
24
Fanlian Huazhuo Formula alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating autophagy and lipid synthesis signaling pathway
8/9/2024 12:51:13 PM | Browse: 232 | Download: 1237
25
Prevalence of nonalcoholic fatty liver disease in patients with hepatitis B: A meta-analysis
7/17/2024 5:55:51 AM | Browse: 376 | Download: 1280
26
Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease
7/1/2024 7:39:37 AM | Browse: 404 | Download: 1160
27
Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease
7/1/2024 7:39:37 AM | Browse: 409 | Download: 988
28
Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology. Long life to the old biomarker !
6/25/2024 10:41:21 AM | Browse: 376 | Download: 1022
29
Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance: A visualization and bibliometric study
6/20/2024 3:42:22 AM | Browse: 442 | Download: 1279
30
Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease
5/27/2024 9:35:51 AM | Browse: 348 | Download: 958
31
Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease
5/27/2024 9:35:51 AM | Browse: 436 | Download: 1016
32
Transient elastography with controlled attenuation parameter for the diagnosis of colorectal polyps in patients with nonalcoholic fatty liver disease
4/16/2024 7:57:40 AM | Browse: 272 | Download: 1244
33
Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions
4/12/2024 4:45:44 PM | Browse: 324 | Download: 947
34
Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis
3/27/2024 1:28:19 PM | Browse: 320 | Download: 1354
35
Investigating the causal associations between five anthropometric indicators and nonalcoholic fatty liver disease: Mendelian randomization study
3/1/2024 2:45:04 AM | Browse: 367 | Download: 1176
36
Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity
1/26/2024 7:56:29 AM | Browse: 675 | Download: 1779
37
Metabolic disease and the liver: A review
1/23/2024 9:31:45 AM | Browse: 718 | Download: 1362
38
Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1
12/27/2023 5:42:53 AM | Browse: 523 | Download: 1617
39
Multifunctional roles of inflammation and its causative factors in primary liver cancer: A literature review
12/25/2023 6:03:15 AM | Browse: 449 | Download: 1466
40
Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography
12/6/2023 8:08:49 AM | Browse: 592 | Download: 1711
41
Global burden of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease, 1990-2019
11/24/2023 6:10:12 AM | Browse: 503 | Download: 1972
42
Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023)
9/25/2023 9:07:43 AM | Browse: 643 | Download: 1601
43
Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway
8/18/2023 10:08:22 AM | Browse: 519 | Download: 1970
44
Antagonizing adipose tissue-derived exosome miR-103-hepatocyte phosphatase and tensin homolog pathway alleviates autophagy in non-alcoholic steatohepatitis: A trans-cellular crosstalk
8/2/2023 9:29:03 AM | Browse: 564 | Download: 1747
45
F-box only protein 2 exacerbates non-alcoholic fatty liver disease by targeting the hydroxyl CoA dehydrogenase alpha subunit
7/26/2023 11:55:37 AM | Browse: 557 | Download: 1799
46
Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value
6/25/2023 2:17:08 PM | Browse: 564 | Download: 1449
47
Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
5/24/2023 9:31:05 AM | Browse: 617 | Download: 1525
48
Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesis
3/28/2023 12:59:29 PM | Browse: 399 | Download: 1253
49
Emerging role of engineered exosomes in nonalcoholic fatty liver disease
3/22/2023 11:20:34 AM | Browse: 675 | Download: 1761
50
Microbiome-liver crosstalk: A multihit therapeutic target for liver disease
3/17/2023 6:20:53 AM | Browse: 549 | Download: 1519
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.